Breaking News Instant updates and real-time market news.

BJ

BJ's Wholesale

$22.54

(0.00%)

, PSTG

Pure Storage

$13.87

(0.00%)

09:40
08/22/19
08/22
09:40
08/22/19
09:40

Unusually active option classes on open August 22nd

Unusual total active option classes on open include: BJs Wholesale Club (BJ), Pure Storage (PSTG), Groupon (GRPN), Dicks (DKS), Splunk (SPLK), Nordstrom (JWN), Atlassian (TEAM), GameStop (GME), Salesforce (CRM), and Johnson & Johnson (JNJ).

BJ

BJ's Wholesale

$22.54

(0.00%)

PSTG

Pure Storage

$13.87

(0.00%)

GRPN

Groupon

$2.52

(0.00%)

DKS

Dick's Sporting

$32.97

(0.00%)

SPLK

Splunk

$128.51

(0.00%)

JWN

Nordstrom

$26.51

(0.00%)

TEAM

Atlassian

$143.95

(0.00%)

GME

GameStop

$3.55

(0.00%)

CRM

Salesforce

$147.40

(0.00%)

JNJ

Johnson & Johnson

$131.55

(0.00%)

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 28

    Aug

  • 28

    Aug

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 09

    Sep

  • 10

    Sep

  • 15

    Sep

  • 16

    Sep

  • 24

    Sep

  • 01

    Oct

  • 10

    Oct

  • 15

    Oct

  • 15

    Oct

  • 12

    Dec

  • 16

    Dec

BJ BJ's Wholesale
$22.54

(0.00%)

04/01/19
SBSH
04/01/19
UPGRADE
Target $18
SBSH
Neutral
Bed Bath & Beyond upgraded to Neutral from Sell at Citi
Citi analyst Geoff Small upgraded Bed Bath & Beyond (BBBY) to Neutral from Sell and raised his price target for the shares to $18 from $10 after taking over coverage of the name. Citi transferred coverage of Broadlines & Hardlines Retail names to Small. The analyst assumed coverage with Buy ratings on AutoZone (AZO), BJ's Wholesale (BJ), Home Depot (HD), Lowe's (LOW), O'Reilly Automotive (ORLY) and Walmart (WMT). The U.S. consumer remains on "solid footing" amid low unemployment, rising wages, declining gas prices, manageable levels of debt, and elevated consumer confidence, Small tells investors in a research note. However, he points out that we are in the ninth year of the current economic expansion and "the possibility of a macroeconomic slowdown cannot be ignored." The analyst prefers retailers operating in "defensive sectors that are less susceptible to disruption by online competitors," namely auto parts, broadlines and home improvement retail. Small also assumed Advance Auto Parts (AAP), Best Buy (BBY), Costco (COST) and Office Depot (ODP) with Neutral ratings.
07/15/19
DBAB
07/15/19
INITIATION
Target $29
DBAB
Buy
BJ's Wholesale assumed with a Buy at Deutsche Bank
Deutsche Bank analyst Paul Trussell assumed coverage of BJ's Wholesale with a Buy rating and $29 price target, down from his firm's prior target of $29. The analyst continues to see a shift in dollar share with the rise of e-commerce, fresh, and limited assortment stores, in addition to wholesale clubs and supercenters, at the expense of independents and other regional grocers.
07/18/19
LOOP
07/18/19
NO CHANGE
Target $35
LOOP
Buy
BJ's Wholesale executing strategy in a favorable environment, says Loop Capital
Loop Capital analyst Laura Champine kept her Buy rating and $35 price target on BJ's Wholesale after her latest round of store checks. The analyst believes that the company is executing well on its strategies amid a favorable operating environment for warehouse clubs, but still has an opportunity to improve its value proposition and its range of product categories. Champine is modeling 1.5% comps growth for Q2 against a tough 5% comparison in the corresponding quarter last year.
07/11/19
GSCO
07/11/19
INITIATION
Target $29
GSCO
Buy
BJ's Wholesale initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Kate McShane started BJ's Wholesale with a Buy rating and $29 price target. The company "offers the best attributes within retail," or "value and a treasure hunt experience" with a management team focused on driving both top line and margin growth, says the analyst.
PSTG Pure Storage
$13.87

(0.00%)

08/22/19
COWN
08/22/19
NO CHANGE
Target $23
COWN
Outperform
Pure Storage price target lowered to $23 from $28 at Cowen
Cowen analyst Karl Ackerman lowered his price target on Pure Storage to $23 from $28 following Q2 results. The analyst acknowledged the weak storage and computer spending backdrop but said the company is chipping away at market shares. He said 2019 was always an investment year and deferred revenue growth indicates future leverage. Ackerman reiterated his Outperform rating on Pure Storage shares.
08/22/19
MAXM
08/22/19
UPGRADE
MAXM
Buy
Pure Storage upgraded to Buy from Hold at Maxim
08/22/19
BTIG
08/22/19
NO CHANGE
Target $20
BTIG
Buy
Pure Storage price target lowered to $20 from $28 at BTIG
BTIG analyst Edward Parker lowered his price target on Pure Storage to $20, saying that while the company beat expectations on Q2 earnings, it also lowered its FY20 revenue outlook for the second consecutive quarter. The analyst notes that the management is citing a bigger than expected decline in NAND pricing, even though it expects a rebound to come in 2020. Parker still keeps his Buy rating on Pure Storage longer term, stating that the company's buyback program provides evidence of strong fundamentals and adding that he is "encouraged" by its "structural gross margin leadership."
08/22/19
LSCM
08/22/19
NO CHANGE
Target $19
LSCM
Buy
Pure Storage price target lowered to $19 from $22 at Lake Street
Lake Street analyst Eric Martinuzzi pointed to two reasons that Pure Storage gave Q3 and FY20 guidance that was below expectations, namely that NAND flash memory component cost declined faster than anticipated and that the company believes it prudent to take into account competitor commentary regarding macro softness, even though Pure was not hurt by macro weakness in Q2. While "the lower revenue outlook is understandable, this is the second downward revision in as many quarters," stated Martinuzzi, who lowered his price target on Pure Storage shares to $19 from $22 but keeps a Buy rating on the stock.
GRPN Groupon
$2.52

(0.00%)

02/04/19
02/04/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Yelp (YELP) initiated with a Buy at Goldman Sachs while Groupon (GRPN) was initiated with a Neutral, and Match Group (MTCH) and Shutterfly (SFLY) were initiated with a Sell. 2. eHealth (EHTH) initiated with an Outperform at Evercore ISI. 3. Okta (OKTA) initiated with an Equal Weight at Morgan Stanley. 4. Lonestar Resources (LONE) initiated with an Outperform at Cowen. 5. Kopin (KOPN) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/04/19
GSCO
02/04/19
INITIATION
Target $3.5
GSCO
Neutral
Groupon initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Michael Ng started Groupon with a Neutral rating and $3.50 price target. While the company's business model is in transition, its domestic customer base is declining and should continue to do so, particularly as Groupon moderates its domestic marketing spending, Ng tells investors in a research note. However, he believes these "challenges are well understood" at current share levels.
09/14/18
DADA
09/14/18
NO CHANGE
Target $8
DADA
Buy
Groupon is 'attractively priced', says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $8 price target on Groupon, saying the stock is "attractively priced" at current levels with free-cash-flow yield above of 14.8%. The analyst adds that he is "encouraged" by the company's hiring of Sarah Butterfass as its Chief Product Officer. He sees the decision as a reflection of the management's efforts to generate "significant" free cash flow or facilitate the sale of the company to a "strategic buyer", which could unlock up to $12 per share in incremental value for investors.
09/14/18
WEDB
09/14/18
INITIATION
Target $4
WEDB
Neutral
Groupon initiated with a Neutral at Wedbush
Wedbush analyst Ygal Arounian started Groupon with a Neutral rating and $4 price target. Despite an improved margin profile, Groupon has yet to show a steady increase in profit dollars and has not been able to consistently grow the most important part of the business, Local, Arounian tells investors in a research note. The analyst comes out on the sidelines citing Groupon's "current below-ecommerce market growth rates."
DKS Dick's Sporting
$32.97

(0.00%)

07/11/19
GSCO
07/11/19
INITIATION
Target $38
GSCO
Neutral
Dick's Sporting initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Kate McShane started Dick's Sporting Goods with a Neutral rating and $38 price target. The analyst thinks "sluggish" sporting goods sales and competition from both online and vendors will mute the company's sales growth.
05/29/19
BARD
05/29/19
NO CHANGE
Target $36
BARD
Neutral
Dick's Sporting making progress on sales, margins, says Baird
Baird analyst Peter Benedict reiterates a Neutral rating and a $36 price target on Dick's Sporting, but acknowledges that the risk/reward is improving. The analyst notes that Q1 EPS beat expectations on stronger sales/gross margin, and prospects for continued sequential improvement "appear good." While Benedict believes some top-line conservatism appears at play, he sees tariffs remaining "a wildcard."
05/30/19
DBAB
05/30/19
NO CHANGE
Target $42
DBAB
Buy
Dick's Sporting sold off on tariff commentary on call, says Deutsche Bank
Deutsche Bank analyst Mike Baker attributes the post-earnings weakness yesterday in shares of Dick's Sporting Goods to commentary on the earnings call that management has not contemplated the recent increase from 10% to 25% tariffs in their updated guidance. However, this is "somewhat misleading" as the company did implicitly lower its earnings outlook by 4c, when adjusting out the impact of the increased share repurchase, Baker tells investors in a research note. He thinks Dick's updated guidance "embeds a level of conservatism simply due to the tariff uncertainty." The analyst lowered his price target for the shares to $42 from $45 and keeps a Buy rating on Dick's Sporting.
08/07/19
STFL
08/07/19
NO CHANGE
STFL
G-III, Yeti have higher than average risk from List 4 tariffs, says Stifel
Stifel analyst Jim Duffy said the direct, unmitigated impact of a proposed 10% tariff on "List 4" goods imported from China is contained to a single digit percentage headwind to calendar 2020 earnings for most of the 18 Sports and Lifestyle Brands companies he covers, though he identified G-III Apparel (GIII), Yeti (YETI) and potentially Dick's Sporting Goods (DKS) as having higher than group average exposure to the risk. He awaits more tariff details before adjusting estimates, but said he is constructive on higher-end and globally diversified brands, such as Lululemon (LULU), Columbia Sportswear (COLM), Nike (NKE), Under Armour (UAA) and VF Corp. (VFC).
SPLK Splunk
$128.51

(0.00%)

08/22/19
FBCO
08/22/19
NO CHANGE
Target $150
FBCO
Outperform
Splunk price target lowered to $150 from $160 at Credit Suisse
Credit Suisse analyst Brad Zelnick lowered his price target for Splunk to $150 from $160 after the company reported "strong" headline results but "quite surprisingly," fiscal year cash flow was "dramatically" cut due to timing/duration as invoicing shifts to annual terms. The analyst reiterates an Outperform rating on the shares.
08/22/19
GSCO
08/22/19
NO CHANGE
Target $131
GSCO
Neutral
Splunk price target raised to $131 from $119 at Goldman Sachs
Goldman Sachs analyst Kevin Kumar called it "a busy" second fiscal quarter for Splunk, noting the company's revenue outperformance, $550M reduction in cash flow guidance and deal to acquire SignalFx. Despite the major headwind to FY20 cashflow it will cause, he was encouraged to see that Splunk has accelerated its transition from perpetual to license, said Kumar. The analyst, who said he is willing to look past the timing related headwinds to cash flow from the license shift, also said he believes the proposed acquisition of SignalFx should fill key gaps in Splunk's current portfolio. He raised his FY20/21 revenue estimates and increased his price target on Splunk shares $131 from $119 following last night's news, but keeps a Neutral rating on the stock.
08/22/19
BARD
08/22/19
DOWNGRADE
Target $127
BARD
Neutral
Splunk downgraded to Neutral at Baird
As reported previously, Baird analyst Rob Oliver downgraded Splunk to Neutral from Outperform following Q2 results. The analyst cited the company's meaningful OCF reduction that stems from the accelerating move to ratable business and reducing up-front invoice durations. He believes the stock may struggle to break to new highs in coming months as incremental investors wrestle with cash flow uncertainty. Olive maintained his $127 price target on Splunk shares.
08/22/19
JEFF
08/22/19
NO CHANGE
Target $157
JEFF
Buy
Splunk cash flow guidance cut may keep a 'lid on the stock,' says Jefferies
Jefferies analyst John DiFucci said Splunk reported "very strong" Q2 results and gave Q3 guidance that was above consensus, but the company's cash flow guidance cut "may keep a lid on the stock...for now." The $550M net negative swing in operating cash flow guidance is due to a faster than expected transition to a purely renewable mix as perpetual licenses will be only about 1% of Software bookings by year-end and a much lower expected percentage of upfront cash collections for term and cloud deals, explained DiFucci, who believes a new pricing framework will drive greater use and sales for Splunk over time. He maintains a Buy rating and $157 price target on Splunk shares.
JWN Nordstrom
$26.51

(0.00%)

08/15/19
WEDB
08/15/19
NO CHANGE
Target $24
WEDB
Neutral
Nordstrom price target lowered to $24 from $35 at Wedbush
Wedbush analyst Jen Redding lowered her price target for Nordstrom to $24 from $35 as she sees risk to Q2 consensus estimates and back half guidance. Although Off- Price bucked the trend, showing positive monthly cadence sequentially as the second quarter progressed, the analyst is less confident in Full-Price, as her Search model forecasts a decline in total company revenues of 7.8% year over year. Wedbush Promotional Data shows increased year over year discounting, likely exacerbated by weather, and highlights that Nordstrom upped the ante on the semi-annual sale messaging to "up to 50% off" from "up to 40% off" last year - also ratcheting promotions still higher in June with "buy more save more" and "bonus" offers, she adds. Redding reiterates a Neutral rating on the shares.
06/27/19
GSCO
06/27/19
DOWNGRADE
Target $91
GSCO
Sell
Goldman downgrades Ross Stores to Sell, cuts price target to $91 from $102
Goldman Sachs analyst Alexandra Walvis downgraded Ross Stores (ROST) to Sell from Neutral and lowered her price target for the shares to $91 from $102. The analyst is taking a "conservative stance" on the retail sector. The headwinds in Q2 have proven persistent, says the analyst, who sees risk that a second half of the year inflection in earnings growth may not materialize for many companies. Walvis recommends a selective approach in Apparel and prefers stocks with "clear" second half catalysts or strategic actions to drive momentum. She reiterates Buy ratings on both Under Armour (UAA) and Tapestry (TPR) and downgraded both Nordstrom (JWN) and Ross Stores to Sell. She believes the recent rally in Ross shares is overdone given the risks that recent execution challenges persist. Further, Walvis forecasts limited upside from the company's strategic initiatives.
06/27/19
06/27/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. FactSet (FDS) downgraded to Sell from Neutral at Goldman Sachs with analyst George Tong saying he believes FactSet faces "secular challenges" in the financial services end-market due to the implementation of MiFID II and the ongoing shift from active to passive asset management. 2. Travelers (TRV) downgraded to Sell from Hold at Deutsche Bank with analyst Joshua Shanker saying the commercial Property & Casualty sector is "largely overvalued" due to an intra-sector exodus from more rate-sensitive financials into P&C insurance stocks. 3. Sempra Energy (SRE) downgraded to Neutral from Buy at BofA/Merrill with analyst Julien Dumoulin-Smith citing share outperformance and moderating expectations on expedited CA legislation by the July 12 deadline combined with a potential credit downgrade. 4. W. R. Berkley (WRB) downgraded to Sell from Hold at Deutsche Bank with analyst Joshua Shanker saying investors are mistaking the appreciation in Property and Casualty insurance stocks as the "fruit of renewal rate pricing increases in the P&C market." 5. Ross Stores (ROST) and Nordstrom (JWN) downgraded to Sell from Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/02/19
UBSW
07/02/19
DOWNGRADE
Target $33
UBSW
Neutral
Nordstrom downgraded to Neutral from Buy at UBS
UBS analyst Jay Sole downgraded Nordstrom to Neutral from Buy and lowered his price target for the shares to $33 from $65. The analyst says his firm's data shows that U.S. high income consumer spending outlook over the next 90 days has softened. Further, a new UBS Evidence Lab survey reveals Nordstrom's competitive positioning is weakening, Sole tells investors in a research note. As a result, the analyst thinks the company will be unable to beat consensus earnings expectations.
TEAM Atlassian
$143.95

(0.00%)

07/26/19
BMOC
07/26/19
NO CHANGE
Target $150
BMOC
Market Perform
Atlassian price target raised to $150 from $110 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target to $150 on Atlassian after its "solid if less than stellar quarter", saying Q4 delivered "impressive" billings and revenue growth but may not move the FY20 consensus too much. While he still expects the company to sustain a 30% growth in FY20, the analyst also does not believe that risk-reward on Atlassian at current valuation is favorable, keeping his Market Perform rating.
07/26/19
BARD
07/26/19
NO CHANGE
Target $150
BARD
Outperform
Atlassian price target raised to $150 from $120 at Baird
Baird analyst Rob Oliver raised his price target on Atlassian to $150 from $120 following strong Q4 results. The analyst said the focus of the conference call centered around the company's strategy to increase investments in cloud products, cloud platform, and migrating customers to these offerings. He said long-term benefits will outweigh the short-term effects that could cause a headwind to 2020 revenue guidance. Oliver reiterated his Outperform rating on Atlassian shares.
07/26/19
KEYB
07/26/19
NO CHANGE
Target $150
KEYB
Overweight
Atlassian price target raised to $150 from $142 at KeyBanc
KeyBanc analyst Alex Kurtz raised his price target for Atlassian to $150 from $142 and retained an Overweight rating, saying the company posted "solid" revenue and leverage upside and guided the fiscal first quarter of 2020 above consensus. Kurtz says Atlassian also outlined initiatives to drive increased Cloud adoption, leading to a one-point revenue headwind for FY20.
07/26/19
DADA
07/26/19
NO CHANGE
Target $155
DADA
Buy
Atlassian price target raised to $155 from $126 at DA Davidson
DA Davidson analyst Rishi Jaluria raised his price target on Atlassian to $155 and kept his Buy rating after its "strong" Q4 results, saying the quarter was driven by the "cloud customer" growth momentum supported by the launch of free trials and "freemium" offerings. The analyst notes that the tailwinds for Atlassian's cloud migrations will grow with more adoption and future price increases. Jaluria also cites the company's "unique" sales model as a factor in the "increasingly-important collaboration software market."
GME GameStop
$3.55

(0.00%)

06/05/19
BNCH
06/05/19
NO CHANGE
Target $5
BNCH
Sell
Benchmark cuts GameStop price target to $5 as business 'burns to the ground'
Benchmark analyst Mike Hickey reiterated his Sell rating on GameStop shares following the company's "disappointing" Q1 sales performance, reiteration of its "dismal" FY19 forecast and elimination of its quarterly cash dividend. He also reduced his price target on the stock from $9 to $5 "as business burns to the ground," telling investors that he sees the company having "little value" amid the industry's on-going transition to the digital economy.
06/05/19
ASCN
06/05/19
DOWNGRADE
ASCN
Hold
GameStop downgraded to Hold from Buy at Ascendiant
Ascendiant analyst Edward Woo downgraded GameStop to Hold from Buy following the company's weak Q1 revenue and FY19 guidance, citing increased concerns about the "digital threat."
07/15/19
LOOP
07/15/19
NO CHANGE
Target $7
LOOP
Hold
GameStop Dutch tender auction a 'sensible' capital allocation, says Loop Capital
Loop Capital analyst Anthony Chukumba kept his Hold rating and $7 price target on GameStop, saying the company's plans to repurchase 12M shares of its common stock under a modified Dutch tender auction is a "sensible capital allocation" but does not change his view of it as a "show-me story". The analyst raises his FY19 EPS view on GameStop to $1.27 from $1.19 to reflect the impact, but maintains that the valuation on the stock is appropriate given the continued secular decline in its core video game business.
08/20/19
BOFA
08/20/19
NO CHANGE
Target $2.5
BOFA
Underperform
GameStop price target lowered to $2.50 from $4 at BofA/Merrill
BofA/Merrill analyst Curtis Nagle lowered his price target on Underperform-rated GameStop to $2.50 from $4. In a research note to investors, Nagle says he sees risk to earnings due to a weak title slate for the year, continued deterioration in the highly profitable pre-owned segment, and a view that a turnaround plan will take time to take hold, if at all, given GameStop's rapid decline in EBIT.
CRM Salesforce
$147.40

(0.00%)

08/22/19
MZHO
08/22/19
INITIATION
Target $225
MZHO
Buy
Workday initiated with a Buy at Mizuho
As previously reported, Mizuho analyst Siti Panigrahi initiated Workday (WDAY) with a Buy rating and a price target of $225 as part of his broader research note into the cloud HCM software sector. The analyst contends that similar to Salesforce's (CRM) front-office suite, the company's product is "well positioned" to become the "de-facto cloud vendor" for the back office applications, also achieving a dominant position in the next-gen enterprise application segment.
08/20/19
BMOC
08/20/19
NO CHANGE
Target $185
BMOC
Outperform
Salesforce stock 'very attractively valued', says BMO Capital
BMO Capital analyst Keith Bachman kept his Outperform rating and $185 price target on Salesforce, also updating his model to reflect the company's Tableau acquisition and lowering its FY20 and FY21 EPS estimates by 9c and 16c to $2.79 and $3.22 respectively. The analyst believes the company had a "solid" July and that the stock is "very attractively valued" in the high-growth software space, but also notes that its "aggressive" M&A strategy has continued to push out the expansion of its margins while negatively impacting its year-to-date performance.
08/20/19
STFL
08/20/19
NO CHANGE
Target $185
STFL
Buy
Salesforce sets up for great 'catch-up trade,' says Stifel
Stifel analyst Tom Roderick said consensus opinion from shareholders on Salesforce's deal to buy Tableau has been "one of concern and criticism," but he believes that the business remains healthy and his feedback on Tableau from checks has been very positive. He thinks Salesforce reporting in-line results in Q2 against low expectations will set up the stock for a great "catch-up trade" ahead of its Dreamforce event and the seasonally strong second half. Ahead of the company's report, due after the close on August 22, Roderick keeps a Buy rating and $185 price target on Salesforce shares.
08/20/19
WEDB
08/20/19
NO CHANGE
Target $184
WEDB
Outperform
Salesforce price target lowered to $184 from $192 at Wedbush
Wedbush analyst Steve Koenig lowered his price target for Salesforce to $184 from $192, while reiterating an Outperform rating on the stock. The analyst acknowledges that macroeconomic concerns, currency headwinds, and some skepticism about the Tableau acquisition have pressured the shares over the last 30 days, but he expects some relief from the upcoming Q2 results, despite additional FX headwinds. Although Salesforce's sales automation in the U.S. enterprise market is fairly saturated, Koenig's checks see "good opportunity for growth" in international markets and verticals, with the company attacking the latter opportunity by building vertical-specific sales teams across Salesforce's various cloud units. Well-placed industry contacts were relatively positive on the Tableau acquisition, seeing it as a strategic move with good revenue synergy as Salesforce makes the product much more ubiquitous, he adds.
JNJ Johnson & Johnson
$131.55

(0.00%)

07/18/19
PIPR
07/18/19
NO CHANGE
Target $10
PIPR
Overweight
Spring Bank research agreement with NIAID 'smart,' says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff notes that Spring Bank (SBPH) entered into a research agreement with the National Institute of Allergy and Infectious Diseases, or NIAID, to study preclinical HBV antisense oligonucleotides. With the recent Arrowhead (ARWR) partnership with Janssen (JNJ), the analyst sees this as a "smart development program" building on Spring Bank's HBV expertise. Tenthoff also notes that Spring Bank is conducting the Phase IIb CATALYST 1 and 2 trials of 400mg inarigivir monotherapy/combination with Vemlidy in naive and suppressed HBV patients with preliminary data in the second quarter of 2020, while partner Gilead (GILD) is conducting a Phase II study of inarigivir plus Vemlidy in naive and suppressed HBV patients with initial data likely at AASLD in November. He reiterates an Overweight rating and $10 price target on Spring Bank's shares.
08/12/19
GUGG
08/12/19
INITIATION
GUGG
Buy
Genmab initiated with a Buy at Guggenheim
Guggenheim analyst Michael Schmidt started Genmab (GMAB) with a Buy rating and DKK 1,529 price target, stating that he believes the company's antibody technology platform gives it a strong product engine supporting long-term growth. The stock's current valuation is mostly based on Darzalex royalties from partner Johnson & Johnson (JNJ) and cash on the balance sheet with little value attributed to the proprietary and out-licensed pipeline of candidates, but several potential catalysts in the next 12 months could potentially add validation to the company's pipeline, Schmidt tells investors in his initiation note.
07/17/19
RAJA
07/17/19
NO CHANGE
RAJA
Investors shouldn't overreact to drug proposal headlines, says Raymond James
Raymond James analyst Chris Meekins noted that President Donald Trump has indicated an Executive Order on drug pricing is coming soon, but he believes investors "should be cautious not to overreact" to drug related proposal headlines as he "cannot think of a single proposal that was finalized and also survived a court challenge resulting in a negative impact on earnings" yet from the Trump Administration. Given the history of the current White House to date, Meekins said he is increasingly skeptical the Administration will get anything meaningful finalized and overcome legal challenges that will impact drugmakers' earnings before the 2020 election, he tells investors in a healthcare policy note. Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/17/19
MZHO
07/17/19
NO CHANGE
Target $103
MZHO
Buy
Amgen seen by Mizuho as 'most likely' buyer of Celgene's Otezla
In the wake of the recent announcement that Bristol-Myers (BMY) plans to divest Otezla as part of its deal to acquire Celgene (CELG), Mizuho analyst Salim Syed said he has received questions on who could be a realistic buyer. He believes the "most likely" buyer would be Amgen (AMGN), followed by Johnson & Johnson (JNJ), which he would label as a "likely" buyer. Syed identifies the "less likely, but possible" buyers as Eli Lilly (LLY) and Regeneron (REGN). The analyst, who said Otezla is worth anywhere from $5B-$10B depending on the view of sales and synergy potential, keeps a Buy rating and $103 price target on Celgene shares.

TODAY'S FREE FLY STORIES

BAC

Bank of America

$30.12

0.44 (1.48%)

, TPR

Tapestry

$25.16

-0.43 (-1.68%)

19:46
09/15/19
09/15
19:46
09/15/19
19:46
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

BAC

Bank of America

$30.12

0.44 (1.48%)

TPR

Tapestry

$25.16

-0.43 (-1.68%)

T

AT&T

$37.90

-0.46 (-1.20%)

UHAL

Amerco

$379.63

4.21 (1.12%)

GM

General Motors

$38.83

-0.22 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 16

    Oct

  • 23

    Oct

GM

General Motors

$38.83

-0.22 (-0.56%)

19:23
09/15/19
09/15
19:23
09/15/19
19:23
Hot Stocks
President Trump urges General Motors, UAW to resolve contract dispute »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBCI

Glacier Bancorp

$41.37

0.43 (1.05%)

17:04
09/15/19
09/15
17:04
09/15/19
17:04
Conference/Events
Glacier Bancorp management to meet with Janney Montgomery Scott »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 17

    Sep

  • 06

    Nov

16:55
09/15/19
09/15
16:55
09/15/19
16:55
Conference/Events
SunTrust retail/consumer goods analysts to hold a dinner meeting »

Retail/Consumer Goods…

16:55
09/15/19
09/15
16:55
09/15/19
16:55
Conference/Events
SunTrust retail analyst team to hold a dinner meeting »

The Retail/Consumer Goods…

T

AT&T

$37.90

-0.46 (-1.20%)

, CMCSA

Comcast

$46.89

-0.08 (-0.17%)

16:54
09/15/19
09/15
16:54
09/15/19
16:54
On The Fly
Box Office Battle: 'It: Chapter Two' wins weekend again with $40.8M »

"Box Office Battle" is…

T

AT&T

$37.90

-0.46 (-1.20%)

CMCSA

Comcast

$46.89

-0.08 (-0.17%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$60.37

0.06 (0.10%)

LGF.A

Lionsgate

$11.15

-0.065 (-0.58%)

LGF.B

Lionsgate

$10.44

-0.1 (-0.95%)

DIS

Disney

$138.00

0.44 (0.32%)

VIAB

Viacom

$26.05

0.02 (0.08%)

VIA

Viacom

$28.01

-0.1 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

BA

Boeing

$379.87

4.3 (1.14%)

16:34
09/15/19
09/15
16:34
09/15/19
16:34
Periodicals
Boeing board to call for safety changes following 737 Max crashes, NYTimes says »

For the past five months,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FB

Facebook

$186.97

-0.42 (-0.22%)

16:25
09/15/19
09/15
16:25
09/15/19
16:25
Periodicals
Regulators to question Facebook's Libra amid EU concerns, FT reports »

Facebook will be quizzed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

AAPL

Apple

$218.71

-4.4 (-1.97%)

16:22
09/15/19
09/15
16:22
09/15/19
16:22
Periodicals
Apple TV+ premieres with period drama at Tribeca Festival, Reuters reports »

Apple TV+ premiered its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$42.01

-0.77 (-1.80%)

, BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

16:19
09/15/19
09/15
16:19
09/15/19
16:19
Periodicals
New York bans flavored e-cigarettes, Reuters reports »

New York Governor Andrew…

MO

Altria Group

$42.01

-0.77 (-1.80%)

BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$73.01

-1.89 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SPY

SPDR S&P 500 ETF Trust

$300.98

-0.29 (-0.10%)

, SPX

S&P 500

$0.00

(0.00%)

15:52
09/15/19
09/15
15:52
09/15/19
15:52
Periodicals
Spare oil capacity in U.S. hands after Saudi outage, Reuters says »

An attack on Saudi oil…

SPY

SPDR S&P 500 ETF Trust

$300.98

-0.29 (-0.10%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENRFF

Enerflex

$0.00

(0.00%)

15:52
09/15/19
09/15
15:52
09/15/19
15:52
Conference/Events
Enerflex management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SNMSF

Spin Master

$0.00

(0.00%)

15:50
09/15/19
09/15
15:50
09/15/19
15:50
Conference/Events
Spin Master management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 12

    Nov

WFTBF

West Fraser Timber

$0.00

(0.00%)

15:48
09/15/19
09/15
15:48
09/15/19
15:48
Conference/Events
West Fraser Timber management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

GM

General Motors

$38.83

-0.22 (-0.56%)

15:41
09/15/19
09/15
15:41
09/15/19
15:41
Periodicals
UAW calls strike against GM amid financial crisis, CNBC reports »

The United Auto Workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOD

Kodiak Sciences

$14.99

0.805 (5.68%)

15:34
09/15/19
09/15
15:34
09/15/19
15:34
Hot Stocks
Kodiak Sciences announces emerging durability data from Phase 1 study of KSI-301 »

Kodiak Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

LHX

L3Harris Technologies

$207.62

-1.88 (-0.90%)

, ESLT

Elbit Systems

$157.40

-0.2 (-0.13%)

15:30
09/15/19
09/15
15:30
09/15/19
15:30
Hot Stocks
L3Harris Technologies completes sale of Harris Night Vision business »

L3Harris Technologies…

LHX

L3Harris Technologies

$207.62

-1.88 (-0.90%)

ESLT

Elbit Systems

$157.40

-0.2 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

, BJ

BJ's Wholesale

$27.45

-0.02 (-0.07%)

12:56
09/15/19
09/15
12:56
09/15/19
12:56
Conference/Events
Shoptalk to hold a conference »

Grocery Shop to be held…

BAYRY

Bayer

$0.00

(0.00%)

BJ

BJ's Wholesale

$27.45

-0.02 (-0.07%)

BMBOY

Grupo Bimbo

$0.00

(0.00%)

FB

Facebook

$186.97

-0.42 (-0.22%)

FORR

Forrester

$36.33

0.38 (1.06%)

HAIN

Hain Celestial

$21.97

0.25 (1.15%)

HSY

Hershey

$148.68

-2.445 (-1.62%)

IBM

IBM

$143.59

-0.01 (-0.01%)

K

Kellogg

$63.36

-0.33 (-0.52%)

MDLZ

Mondelez

$54.08

-0.7 (-1.28%)

NLSN

Nielsen

$22.45

-0.06 (-0.27%)

PG

Procter & Gamble

$122.11

-0.68 (-0.55%)

PJC

Piper Jaffray

$78.23

-0.39 (-0.50%)

REV

Revlon

$19.86

0.02 (0.10%)

SJM

J.M. Smucker

$106.51

0.72 (0.68%)

TGT

Target

$108.01

-0.92 (-0.84%)

TSN

Tyson Foods

$85.19

1.71 (2.05%)

UL

Unilever; also tag UN

$61.15

-0.52 (-0.84%)

WMT

Walmart

$117.40

0.42 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 15

    Sep

  • 17

    Sep

  • 19

    Sep

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 08

    Oct

  • 27

    Oct

  • 29

    Oct

  • 13

    Nov

  • 14

    Nov

NVCR

Novocure

$79.29

-0.92 (-1.15%)

, RHHBY

Roche

$0.00

(0.00%)

12:54
09/15/19
09/15
12:54
09/15/19
12:54
Conference/Events
American Society for Radiation Oncology to hold annual meeting »

2019 ASTRO Annual Meeting…

NVCR

Novocure

$79.29

-0.92 (-1.15%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$43.72

-0.11 (-0.25%)

SIEGY

Siemens

$0.00

(0.00%)

TDY

Teledyne

$315.15

2.75 (0.88%)

VAR

Varian Medical

$117.39

-2.19 (-1.83%)

HTHIY

Hitachi

$0.00

(0.00%)

GHDX

Genomic Health

$71.69

-1.02 (-1.40%)

ESALY

Eisai

$0.00

(0.00%)

EKTAY

Elekta

$0.00

(0.00%)

BMY

Bristol-Myers

$49.40

-0.22 (-0.44%)

BSX

Boston Scientific

$41.81

-0.42 (-0.99%)

BAYRY

Bayer

$0.00

(0.00%)

AZN

AstraZeneca

$42.76

-0.14 (-0.33%)

ARAY

Accuray

$3.03

(0.00%)

MRK

Merck

$82.61

0.38 (0.46%)

MDT

Medtronic

$109.63

-0.77 (-0.70%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

HOLX

Hologic

$49.72

-0.09 (-0.18%)

ISR

IsoRay

$0.32

-0.0059 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 15

    Sep

  • 16

    Sep

  • 16

    Sep

  • 16

    Sep

  • 16

    Sep

  • 18

    Sep

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 10

    Oct

  • 23

    Oct

  • 29

    Oct

  • 31

    Oct

  • 04

    Nov

  • 13

    Nov

12:50
09/15/19
09/15
12:50
09/15/19
12:50
Conference/Events
SunTrust retail analyst team to hold a dinner meeting »

The Retail/Consumer Goods…

NET

Cloudflare

$17.96

(0.00%)

, AMZN

Amazon.com

$1,837.49

-6 (-0.33%)

07:40
09/15/19
09/15
07:40
09/15/19
07:40
On The Fly
Opening Day: Cloudflare jumps in market debut »

Shares of Cloudflare…

NET

Cloudflare

$17.96

(0.00%)

AMZN

Amazon.com

$1,837.49

-6 (-0.33%)

MSFT

Microsoft

$137.21

-0.33 (-0.24%)

STSA

Satsuma Pharmaceuticals

$16.61

(0.00%)

SWTX

SpringsWorks Therapeutics

$22.75

(0.00%)

SDC

SmileDirectClub

$18.68

1.8 (10.66%)

TXG

10x Genomics

$53.80

0.85 (1.61%)

PTON

Peloton

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

NVST

Envista

$0.00

(0.00%)

XGN

Exagen

$0.00

(0.00%)

DDOG

Datadog

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

NDAQ

Nasdaq

$99.51

0.5 (0.51%)

DHR

Danaher

$141.02

-0.84 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 17

    Sep

  • 17

    Sep

  • 27

    Oct

  • 07

    Nov

  • 18

    Sep

  • 19

    Sep

  • 26

    Sep

04:55
09/15/19
09/15
04:55
09/15/19
04:55
Conference/Events
SunTrust retail/consumer goods analysts to hold a dinner meeting »

Retail/Consumer Goods…

ABT

Abbott

$84.25

-0.96 (-1.13%)

, ADPT

Adaptive Biotechnologies

$43.28

3.49 (8.77%)

13:22
09/14/19
09/14
13:22
09/14/19
13:22
Conference/Events
William Blair diagnostic products/med tech analyst to hold a group luncheon »

Diagnostic Products &…

ABT

Abbott

$84.25

-0.96 (-1.13%)

ADPT

Adaptive Biotechnologies

$43.28

3.49 (8.77%)

BDX

Becton Dickinson

$260.68

-1.41 (-0.54%)

COO

Cooper Companies

$301.95

-3 (-0.98%)

EXAS

Exact Sciences

$106.72

-1.99 (-1.83%)

GH

Guardant Health

$77.54

0.49 (0.64%)

NEO

NeoGenomics

$21.34

-1.22 (-5.41%)

LMNX

Luminex

$22.62

0.1 (0.44%)

HAE

Haemonetics

$125.55

-0.31 (-0.25%)

STAA

STAAR Surgical

$29.21

0.415 (1.44%)

QGEN

Qiagen

$33.97

-0.105 (-0.31%)

NVTA

Invitae

$21.70

-0.2 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 13

    Nov

  • 05

    Dec

CRTO

Criteo

, TWTR

Twitter

13:19
09/14/19
09/14
13:19
09/14/19
13:19
Conference/Events
FBN Securities Tech/Internet analyst to hold a group luncheon »

Technology & Internet…

CRTO

Criteo

TWTR

Twitter

SNAP

Snap

GOOGL

Alphabet Class A

FB

Facebook

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 17

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

T

AT&T

$37.90

-0.46 (-1.20%)

09:06
09/14/19
09/14
09:06
09/14/19
09:06
Periodicals
AT&T stock already benefiting from activist involvement, Barron's says »

AT&T 's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.